Turbo-organomagneesiumamiidi reaktiivide arvutuslik ja eksperimentaalne uuring: kuubaani agregaadid reaktiivsete vaheühenditena Pummereri ühenduses
Orgaaniliste magneesiumreagentide dünaamiline tasakaal on teadaolevalt väga keeruline ja nende komponentide suhteline reaktiivsus on halvasti mõistetav.Siinkohal kasutatakse DFT arvutuste ja kineetiliste katsete kombinatsiooni, et uurida sulfoksiidide ja turbo-organomagneesiumamiidide vahelise Pummereri sidestuse üksikasjalikku reaktsioonimehhanismi.
Erinevate uuritud agregaatide hulgas on näidatud, et enneolematud heterometallilised avatud kuubaanstruktuurid annavad soodsaid tõkkeid kooskõlastatud anioon-anioon sidestamise / S-O lõhustamisetapi kaudu. Lisaks struktuurilisele uudishimule tutvustavad want tulemused avatud kuupaanorgaanilisi metallelemente peamiste reaktiivsete vaheühenditena turbo-orgaaniliste magneesiumamiidide segudes.
Toiduõli oksüdatsiooni visuaalne määramine polüvinüülalkoholist ja Schiffi reagendist valmistatud nanokiudmatiga
• Toiduõlide oksüdeerumise visuaalseks määramiseks töötati välja kiudmatt, mis põhineb Schiffi reagendi ja aldehüüdide kolorimeetrilisel reaktsioonil – lipiidide oksüdeerumisel moodustunud peamisel lenduval ainel.
Polüvinüülalkoholi (PVA) ja Schiffi reagendi segud, mis sisaldasid erinevaid koguseid glütserooli, tsentrifuugiti kiudmatte moodustamiseks.
• Uuriti PVA / Schiffi reaktiivkiu mattide reaktsiooni gaasilisele heksaanalile (mudelaldehüüd). Oksüdeeritud sojaubade õlisid kasutati PVA / Schiffi reaktiivkiu mati efektiivsuse hindamiseks õlide oksüdatsiooni näitamisel. Tulemused näitasid, et saadud kiudmatite keskmine kiuddiameeter oli alla 100 nm.
• Kokkupuutel heksaanaga muutusid kiudmatid valgest lillaks. Suurem glütserooli kogus viis kiudmatite suurema värvimuutuseni ja lühema reaktsiooniaja heksanaalini. Mati värvimuutuse ja heksaanaalse kontsentratsiooni (15–117 μmol L-1) vahel täheldati lineaarset suhet (R2 = 0,96).
• Matta visuaalse määramise piir heksanaalil oli 29 μmol L-1. PVA / Schiffi reaktiivkiudmati värvimuutust suurendati sojaõli oksüdeerumise suurenemisega. Seitsmest testitud sojaoaõlist suutis PVA / Schiffi reaktiivkiudmatt õigesti näidata kuue õli oksüdatsiooniastmeid.
Tulemus näitas, et välja töötatud visuaalse määramise meetod on paljulubav meetod toiduõlide oksüdeerumise näitamiseks, mida mittespetsialistid saavad hõlpsasti läbi viia. Graafiline abstrakt.
Polümeeriga tugeva vaskasiidi, CuN3, nanoosakeste (CANP) sünteesimiseks on kasutatud ühte poti, märjal keemilisel viisil. Hübriidsüsteemi kasutati asiidi-alküüntsüklolisa reaktsiooni katalüsaator-cum-reaktiivina triasoolimolekulide ehitamiseks asendatud bensüülbromiidi ja terminaalse alküüni abil.
Elektrooni annetav rühm, mis sisaldas terminaalset alküüni, tekitas 5-alkünüül-1,4-disubstitud triasooliprodukti, samas kui terminaalse elektronide eraldava rühmaga alküünimolekul hõlbustas 1,4-asendatud triasooli molekuli moodustumist.
Uus fluorestsentsmärgistusega reagent 2- (9-akridoon) etüülkloroformiaat ja selle rakendamine meeproovides olevate vabade aminohapete analüüsimiseks HPLC abil, fluorestsentsi tuvastamise ja identifitseerimisega veebipõhise ESI-MS abil
• Selles uuringus töötati välja, sünteesiti ja rakendati vabade aminohapete määramiseks fluorestsentsdetektoriga (HPLC) kõrgtehnoloogilise vedelikkromatograafiaga uus fluorestseeruv märgistusreagent 2- (9-akridoon) etüülkloroformiaat (AEC-Cl). -FLD).
• Vabad aminohapped märgistati AEC-Cl abil kiiresti ja tõhusalt aluselise katalüsaatori (pH 9,0) juuresolekul 5 minuti jooksul toatemperatuuril (25 ° C). Derivaatidel olid suurepärased stabiilsuse ja fluorestsentsi omadused, maksimaalse ergastuse ja emissiooni lainepikkused vastavalt lainepikkustel 268 nm ja 438 nm.
• 22 tüüpi looduslike aminohapete derivaadid eraldati Hypersil ODS C18 kolonnis gradientelueerimisega täielikult. Optimaalsetes tingimustes näitasid kalibreerimiskõverad suurepäraseid lineaarseid vastuseid, korrelatsioonikordajatega R2> 0,9994. Avastamis- ja kvantifitseerimispiirid olid vastavalt vahemikus 0,61–2,67 μg kg-1 ja 2,07–8,35 μg kg-1.
• Seetõttu rakendati AEC-Cl edukalt meeproovide vabade aminohapete jälgede tuvastamiseks. Graafiline kokkuvõte Mesi vabade aminohapete määramiseks fluorestsentsdetektoriga kasutati uudset fluorestseeruvat märgistusreagenti.
Pühvli (Bubalus bubalis) munarakkude partenogeneetiline aktiveerimine: erinevate aktiveerimisreagentide ja erinevate söötmete võrdlus nende arengupädevuse ja arenguga reguleeritud geenide kvantitatiivse ekspressiooni osas
See uuring viidi läbi selleks, et võrrelda erinevate meetodite efektiivsust pühvli A + B ja C + D kvaliteediga ootsüütide aktiveerimiseks partenogeneetiliselt ning ootsüütide in vitro arengupädevuse ja mõne olulise geeni ekspressiooni uurimiseks partenootide erinevates arenguetappides.
A + B-ootsüütide protsent (62,16 ± 5,06%, vahemik 53,8–71,3%) oli oluliselt suurem (P <0,001), võrreldes tapamajast saadud C + D-ootsüütide (37,8 ± 5,00%, vahemik 28,6–46,1%) protsendiga pühvli munasarjad. Kõigist kombinatsioonidest andis nii A + B- kui ka C + D-klassi ootsüütide kõrgeima lõhustumise ja blastotsüütide saagise etanooli aktiveerimine, millele järgnes kultiveerimine in vitro lõhustuskeskkonnas.
Rakkude koguarv, raku sisemise massi / trofektodermi suhe ja A + B rühma blastotsüstide apoptootiline indeks erinesid oluliselt (P <0,05) nende C + D analoogidest. Arenguliselt reguleeritud geenide ekspressioonimustrite staatuse kindlakstegemiseks uuriti kummel-ootsüütide komplekside ekspressiooni, viljastumist, arengupädevust ja apoptootiliste geenide esinemist erinevates etappides ka partenogeneetiliselt toodetud pühvlite embrüodes ja see näitas, et eespool nimetatud geenidel oli varases embrüonaalses arengus roll.
Kohapealne check TBA jääkide taseme määramiseks 18 F-radiotraktoril inimtervishoius Dragendorffi reagendi abil
Kasutades [18F] tetrabutüülammooniumfluoriidi ([18F] TBAF) 18F-märgistatud radiotrailerite sünteesis kliinilise positronemissioonitomograafia (PET) pildistamiseks, on vaja kinnitada, et jääk-TBA sisaldus formulatsioonides ei ületa kehtestatud spetsifikatsioone (≤ 2,6 mg patsiendi annuse kohta).
Ajalooliselt on see saavutatud HPLC abil, kuid see on lühiajaliste PET-radiotehnika jaoks aeganõudev ja piiratud kulukate seadmete vajadusega. See ajendas meid kasutama TLC jääk-TBA määramiseks TLC-testi ja oleme välja töötanud uue meetodi, milles kasutatakse Dragendorffi reagenti. Siinkohal kirjeldame TLC meetodi üksikasju ja kasutame seda TBA jäägi kvantifitseerimiseks 6- [18F] fluoro-DOPA erinevates preparaatides.
Lihtne reaktiivivaba lähenemine, kasutades kelaativa aine asendajana elektrilahendust kahevalentsete katioonide genoomianalüüsi pärssimise käsitlemisel
Elektrilahendusega töötlemine osutus kelaativa toimeaine elujõuliseks asendamiseks genoomianalüüsides. Kahevalentne katioon Mg2 + pärsib DNA hübridisatsioonil põhinevate genoomsete testide toimimist, seondudes DNA-ga ja häirides DNA hübridisatsiooni.
Siiani olid kelaativad ained, näiteks etüleendiamiintetraäädikhape (EDTA), ainus võimalus proovides Mg2 + esinemise kõrvaldamiseks. Kuid EDTA on tuntud keskkonnasaaste.
Selles töös kasutasime edukalt elektrilahendust EDTA asemel, et muuta Mg2 + nõrgaks. Selle esialgset efektiivsust täheldati esmalt tsirkulaarse dikroismi (CD) ja zeta potentsiaalanalüüside abil. Pärast elektrilahendusega töötlemist oli CD nihke vähenemine lainepikkusel 280 nm 10-Three M ja 10-Eight M Mg2 + proovide puhul märkimisväärne. Samuti taastati Mg2 + koormatud proovide beeta-potentsiaal väärtuselt -4,71 ± 1,38 kuni -20,59 ± 6,37 mV pärast elektrilahendusega töötlemist.
Nii CD-nihe kui ka beeta-potentsiaali muutused viitasid sellele, et 2-minutiline elektrilahendusravi võib takistada Mg2 + seondumist DNA-ga. Elektrilahenduse ravi täielikku efektiivsust demonstreeriti genoomse testi variandi (NanoGene check) jõudluse taastumisega (~ 15% kontrollist), analüüsides samal ajal Mg2 + koormatud proove (10-5-10-Three M).
Eeldades, et aastas analüüsitakse 10 miljonit proovi, võimaldaks kavandatav elektrilahenduse töötlus (∼50 mW proovi kohta) meil kaubelda keskkonna saastumisega ~ 50 kg ohtliku EDTA-ga ühe 250 W STC (standardsed katsetingimused) päikesepaneeliga.
Taimeviirused ja bakteriofaagipõhised reaktiivid diagnoosimiseks ja raviks
Viiruse nanotehnoloogia kasutab ära viiruste kokkupandavaid nanostruktuure, mida on looduses juba palju. Täpselt määratletud molekulaararhitektuuriga pakuvad viiruslikud nanokandjad enneolematuid võimalusi täpseks struktuuriliseks ja funktsionaalseks manipuleerimiseks geenitehnoloogia ja / või bioortogonaalsete keemiate abil.
Sel viisil saab neid sihtotstarbeliseks laadimiseks laadida erinevate molekulkoormustega.
Imetajate viirused on kliinikus juba loodud geeniteraapia ja immunoteraapia jaoks ning inaktiveeritud viiruseid või viirusetaolisi osakesi on pikka aega kasutatud vaktsiinidena. Hiljuti on taimeviirused ja bakteriofaagid välja töötatud nanokandjatena diagnostiliseks kuvamiseks, vaktsiinide ja ravimite kohaletoimetamiseks ning kombineeritud diagnoosimiseks / teraapiaks (teranostika).
Nende uudsete viirusepõhiste tööriistade esimene laine on kliinilise arengu lõpule viinud ja on valmis kliinilist praktikat mõjutama.
Description: A polyclonal antibody against CA14. Recognizes CA14 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against SF1 (Ab-82). Recognizes SF1 (Ab-82) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500
Description: A polyclonal antibody against SF1 (Ab-82). Recognizes SF1 (Ab-82) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500
Description: A polyclonal antibody against CCT7. Recognizes CCT7 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against CCT7. Recognizes CCT7 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against Phospho-MAPT (Ser404). Recognizes Phospho-MAPT (Ser404) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200
Description: A polyclonal antibody against Phospho-MAPT (Ser404). Recognizes Phospho-MAPT (Ser404) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200
Description: A polyclonal antibody against CST1. Recognizes CST1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF;IHC:1:50-1:100, IF:1:100-1:500
Description: A polyclonal antibody against CST1. Recognizes CST1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF;IHC:1:50-1:100, IF:1:100-1:500
Description: A polyclonal antibody against Phospho-CCND1 (Ser90). Recognizes Phospho-CCND1 (Ser90) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000
Description: A polyclonal antibody against Phospho-CCND1 (Ser90). Recognizes Phospho-CCND1 (Ser90) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000
Description: A polyclonal antibody against Histone H3K27me3. Recognizes Histone H3K27me3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF, IP, ChIP;WB:1:500-1:2000, IHC:1:50-1:200, IF:1:50-1:200, IP:1:50-1:200, ChIP:1:50-1:200
Description: A polyclonal antibody against Histone H3K27me3. Recognizes Histone H3K27me3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF, IP, ChIP;WB:1:500-1:2000, IHC:1:50-1:200, IF:1:50-1:200, IP:1:50-1:200, ChIP:1:50-1:200
Description: A polyclonal antibody against MYOM1. Recognizes MYOM1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100
Description: A polyclonal antibody against MYOM1. Recognizes MYOM1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100
Description: A polyclonal antibody against ADD3. Recognizes ADD3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against ADD3. Recognizes ADD3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against TP53 (Ab-315). Recognizes TP53 (Ab-315) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000
Description: A polyclonal antibody against TP53 (Ab-315). Recognizes TP53 (Ab-315) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000
Description: A polyclonal antibody against PRLR. Recognizes PRLR from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000
Description: A polyclonal antibody against PRLR. Recognizes PRLR from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000
Description: A polyclonal antibody against PPP2R3C. Recognizes PPP2R3C from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against PPP2R3C. Recognizes PPP2R3C from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against BAGE2. Recognizes BAGE2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100
Description: A polyclonal antibody against BAGE2. Recognizes BAGE2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100
Description: A polyclonal antibody against PIK3R1/PIK3R3 (Ab-467/199). Recognizes PIK3R1/PIK3R3 (Ab-467/199) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100
Description: A polyclonal antibody against PIK3R1/PIK3R3 (Ab-467/199). Recognizes PIK3R1/PIK3R3 (Ab-467/199) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100
Description: A polyclonal antibody against MAP2K1 (Ab-291). Recognizes MAP2K1 (Ab-291) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200
Description: A polyclonal antibody against MAP2K1 (Ab-291). Recognizes MAP2K1 (Ab-291) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200
Description: A polyclonal antibody against Phospho-HSF1 (Ser307). Recognizes Phospho-HSF1 (Ser307) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:1000, IF:1:100-1:200
Description: A polyclonal antibody against Phospho-HSF1 (Ser307). Recognizes Phospho-HSF1 (Ser307) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:1000, IF:1:100-1:200
Description: A polyclonal antibody against ASCL2. Recognizes ASCL2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against ASCL2. Recognizes ASCL2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against HNRNPC. Recognizes HNRNPC from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500
Description: A polyclonal antibody against HNRNPC. Recognizes HNRNPC from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500
Description: A polyclonal antibody against GZMH. Recognizes GZMH from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:3000, IF:1:100-1:500
Description: A polyclonal antibody against GZMH. Recognizes GZMH from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:3000, IF:1:100-1:500
Description: A polyclonal antibody against Phospho-SYT1 (Ser309). Recognizes Phospho-SYT1 (Ser309) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IF;IF:1:100-1:200
Description: A polyclonal antibody against Phospho-SYT1 (Ser309). Recognizes Phospho-SYT1 (Ser309) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IF;IF:1:100-1:200
Description: A polyclonal antibody against NRSN1. Recognizes NRSN1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against NRSN1. Recognizes NRSN1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against RABL2A. Recognizes RABL2A from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against RABL2A. Recognizes RABL2A from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against HDAC3. Recognizes HDAC3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500
Description: A polyclonal antibody against HDAC3. Recognizes HDAC3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500
Description: A polyclonal antibody against AKR1A1. Recognizes AKR1A1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against AKR1A1. Recognizes AKR1A1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against CLCN4. Recognizes CLCN4 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:200, IF:1:100-1:200
Description: A polyclonal antibody against CLCN4. Recognizes CLCN4 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:200, IF:1:100-1:200
Description: A polyclonal antibody against ATF1. Recognizes ATF1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:3000, IF:1:100-1:500
Description: A polyclonal antibody against ATF1. Recognizes ATF1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:3000, IF:1:100-1:500
Description: A polyclonal antibody against Phospho-MEF2A (Ser408). Recognizes Phospho-MEF2A (Ser408) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100
Description: A polyclonal antibody against Phospho-MEF2A (Ser408). Recognizes Phospho-MEF2A (Ser408) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100
Description: A polyclonal antibody against WISP2. Recognizes WISP2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000
Description: A polyclonal antibody against WISP2. Recognizes WISP2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000
Description: A polyclonal antibody against Phospho-GRIN2B (Tyr1474). Recognizes Phospho-GRIN2B (Tyr1474) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:1000, IF:1:100-1:200
Description: A polyclonal antibody against Phospho-GRIN2B (Tyr1474). Recognizes Phospho-GRIN2B (Tyr1474) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:1000, IF:1:100-1:200
Description: A polyclonal antibody against PMAIP1. Recognizes PMAIP1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100
Description: A polyclonal antibody against PMAIP1. Recognizes PMAIP1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100
Description: A polyclonal antibody against Phospho-ZAP70 (Tyr319). Recognizes Phospho-ZAP70 (Tyr319) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200
Description: A polyclonal antibody against Phospho-ZAP70 (Tyr319). Recognizes Phospho-ZAP70 (Tyr319) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200
Description: A polyclonal antibody against RPS4X. Recognizes RPS4X from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:3000, IF:1:100-1:500
Description: A polyclonal antibody against RPS4X. Recognizes RPS4X from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:3000, IF:1:100-1:500
Description: A polyclonal antibody against TUBB3. Recognizes TUBB3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100
Description: A polyclonal antibody against TUBB3. Recognizes TUBB3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100
Description: A polyclonal antibody against NT5C1B. Recognizes NT5C1B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF;IF:1:100-1:500
Description: A polyclonal antibody against NT5C1B. Recognizes NT5C1B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF;IF:1:100-1:500
Description: A polyclonal antibody against AKT1 (Ab-450). Recognizes AKT1 (Ab-450) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200
Description: A polyclonal antibody against AKT1 (Ab-450). Recognizes AKT1 (Ab-450) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200
Description: A polyclonal antibody against Phospho-MAP2K4 (Ser80). Recognizes Phospho-MAP2K4 (Ser80) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200
Description: A polyclonal antibody against Phospho-MAP2K4 (Ser80). Recognizes Phospho-MAP2K4 (Ser80) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200
Description: A polyclonal antibody against RAB29. Recognizes RAB29 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against RAB29. Recognizes RAB29 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against KIR2DL5B. Recognizes KIR2DL5B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF;IF:1:100-1:500
Description: A polyclonal antibody against KIR2DL5B. Recognizes KIR2DL5B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF;IF:1:100-1:500
Description: A polyclonal antibody against IKZF3. Recognizes IKZF3 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against IKZF3. Recognizes IKZF3 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against USP13. Recognizes USP13 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100
Description: A polyclonal antibody against USP13. Recognizes USP13 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100
Description: A polyclonal antibody against ABCD4. Recognizes ABCD4 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against ABCD4. Recognizes ABCD4 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against AATF. Recognizes AATF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against AATF. Recognizes AATF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against MOB1B. Recognizes MOB1B from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against MOB1B. Recognizes MOB1B from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against PLG. Recognizes PLG from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against PLG. Recognizes PLG from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against OXR1. Recognizes OXR1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100
Description: A polyclonal antibody against OXR1. Recognizes OXR1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100
Description: A polyclonal antibody against NBPF5P. Recognizes NBPF5P from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against NBPF5P. Recognizes NBPF5P from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000
Description: A polyclonal antibody against KCNJ4. Recognizes KCNJ4 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000